IMNM earnings: a negative outcome, -9.5%

On May 12, 2021, Immunome Inc. reached its earnings. The result was a negative outcome, and the stock moved -9.5% in the window around the event. It had already run -26.0% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.